 This trial attempts to investigate whether the dosage frequency has an effect on the treatment efficacy and cognitive outcomes of magnetic seizure therapy MST among schizophrenia patients. Half of the participants will be recruited to receive 25 Hz MST, while the other half will be recruited to 50 Hz MST. 